Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood
Sponsored by HelixBind, Inc.
About this trial
Last updated 6 years ago
Study ID
20031
Status
Unknown status
Type
Observational
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 5 years ago
What is this trial about?
The purpose of this study is to assess the effectiveness of RaPID/BSI by testing its
performance compared to blood cultures collected prospectively from consented subjects.
What are the participation requirements?
Inclusion Criteria
- Determined to have a positive blood culture.